MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models (Q40751656)
Jump to navigation
Jump to search
scientific article published on February 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models |
scientific article published on February 2002 |
Statements
1 reference
MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models (English)
1 reference
Mikihiko Naito
1 reference
Yasuhiro Matsuba
1 reference
Shigeo Sato
1 reference
Hiroshi Hirata
1 reference
Takashi Tsuruo
1 reference
1 February 2002
1 reference
1 reference
8
1 reference
2
1 reference
582-588
1 reference
Identifiers
1 reference